Home › COPD › California › Santa Clarita
COPD clinical trials in Santa Clarita, CA
3 studies for COPD are looking for participants at sites in and around Santa Clarita (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- California Medical Research Associates - Northridge- Site Number : 8400089, Northridge · 11 mi away
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RecruitingPhase 2
- California Medical Research Associates Inc., Northridge · 11 mi away
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2/3
- California Medical Research Associates, Northridge · 11 mi away
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA24 studies
- Miami, FL18 studies
- Birmingham, AL17 studies
- Boston, MA17 studies
- Houston, TX16 studies
- Orlando, FL15 studies
- Baltimore, MD15 studies
- Chicago, IL15 studies
- Dallas, TX13 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Winston-Salem, NC10 studies
Other studies in Santa Clarita
- Obesity8 studies
- Heart Failure7 studies
- Atopic Dermatitis (Eczema)6 studies
- Type 2 Diabetes6 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Asthma4 studies
- Hidradenitis Suppurativa4 studies
- Arrhythmia4 studies
- Bradycardia4 studies
- Chronic Kidney Disease4 studies
- Eczema4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.